Chronic Disease Models
Chronic Disease Models - Related Videos
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
0 Views •
Cited by 7 •
2017
This study describes the successful generation of a new chronic obstructive pulmonary disease (COPD) animal model by repeatedly exposing mice to high concentrations of ozone.
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
0 Views •
Cited by 25 •
2014
The degree of vascular dysfunction and contributing physiological mechanisms can be assessed in patients with chronic kidney disease by measuring brachial artery flow-mediated dilation, aortic pulse-wave velocity, and vascular endothelial cell protein expression.
09:52
A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites
0 Views •
Cited by 15 •
2014
Animal models have proven to be invaluable tools in defining host and pathogen specific mechanisms that contribute to the development of chronic inflammation. Here we describe a mouse model of oral infection with the human pathogen Porphyromonas gingivalis and detail methodologies to assess the progression of inflammation at local and systemic sites.
06:28
An Obstructive Chronic Pancreatitis Model Established Through Electrocoagulation
0 Views •
2025
The present protocol describes a novel approach to modeling chronic obstructive pancreatitis, which involves visualization of the pancreatic duct and electrocoagulation of the pancreatic duct to cause pancreatic duct obstruction.
09:01
Chronic Salmonella Infected Mouse Model
0 Views •
Cited by 12 •
2010
Establish a chronic bacterial infected mouse model with persistent Salmonella typhimurium colonization in intestine for 27 weeks.
FAQs
Continued exposure can maintain inflammatory signaling rather than allowing the response to resolve. Over time, this sustained activity is associated with immune-cell dysfunction, tissue damage, and tissue remodeling. Studying these linked changes helps researchers connect the persistence of an infectious or antigenic stimulus with the later development of chronic immune dysregulation.
The transition identifies biological changes that may not be visible during an early infection. Chronic disease models let researchers examine how an initially infectious process becomes persistent and how prolonged immune activity contributes to tissue injury. This connection can clarify why some infections continue and can reveal points where targeted interventions may alter disease progression.
These systems can reproduce or examine inflammatory signaling, immune-cell dysfunction, tissue damage, and remodeling as disease continues. Considering these outcomes together is important because persistent disease is not represented only by the presence of a pathogen or antigen. The combined pattern helps investigators investigate mechanisms and identify measurable changes associated with long-term disease.
Each system provides a different experimental view of persistent disease biology. Animal models, cell cultures, organoids, and computational systems can all support investigation of disease mechanisms, biomarkers, vaccines, or therapies, but they represent biological change in different experimental settings. Using these approaches allows researchers to study chronic immune responses under controlled conditions from complementary perspectives.
Researchers examine sustained pathogen exposure or antigen persistence together with the immune and tissue responses that follow. The analysis may focus on inflammatory signaling, immune-cell dysfunction, tissue damage, or remodeling over time. This approach places prolonged host responses within an infection-related context and helps relate observable disease changes to underlying immune mechanisms.
Controlled models provide settings in which researchers can test vaccines or therapies against biological changes associated with long-term disease. Evaluation can extend beyond the initial infection to include persistent immune responses, inflammatory signaling, tissue injury, and remodeling. The resulting information can help assess whether an intervention addresses mechanisms linked to chronic infection or immune dysregulation.
Chronic disease models can generate evidence about disease mechanisms and identify biomarkers associated with persistent biological change. They can also provide controlled systems for evaluating vaccines and therapies. In immunology and infection studies, these outputs help connect long-term immune responses with disease progression and support the search for interventions directed at specific pathological processes.